Description
Join us for an insightful webinar exploring the evolving landscape of hypercortisolism, from its historical origins to the latest advancements in screening and clinical management. Our expert speakers will provide a comprehensive overview, beginning with a historical perspective on Cushing syndrome and the progressive understanding of hypercortisolism. The session will then delve into key screening guidelines, including the physiological basis of the dexamethasone suppression test, to enhance early detection. Finally, we will examine the intersection of hypercortisolism and challenging-to-manage type 2 diabetes (T2D), discussing emerging data on its prevalence, clinical implications, and best practices for identifying at-risk individuals. This webinar is essential for healthcare professionals looking to refine their approach to diagnosing and managing hypercortisolism in complex patient populations.
This 30-minute activity was originally presented on 4/29/2025.
This webinar is the first of a two-part series. Register for part 2, "Unmasking Hypercortisolism – A Case-Based Approach to Screening and Diagnosis," here: https://www.adces.org/event/WEBI250522
Before watching this webinar, we encourage you to view this recorded webinar from October 2024, "A Closer Look at Difficult-to-Manage Diabetes – Is Cortisol at Play?" here: https://www.adces.org/product/WEBC241022
Learning Objectives
At the end of this presentation,
participants will be able to:
-- Recognize the evolving understanding of hypercortisolism and its relevance in modern clinical practice.
-- Apply evidence-based recommendations for selecting and interpreting initial screening tests for hypercortisolism.
-- Evaluate the prevalence and impact of hypercortisolism in individuals with challenging-to-manage T2D.
Intended Audience
This activity is designed for diabetes care and education specialists, including nurses, dietitians, pharmacists, PAs, physicians, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.
Sponsor
This webinar is sponsored by Corcept Therapeutics.
Disclaimer
There is no CE/CME credit for this activity.
Access
Period
You
will have access to this learning activity for a period of six months after you
enroll, or whenever the activity expires (whichever comes
first).
Originally presented
on: 4/29/2025
Expiration
date: 4/29/2027